BAJAJ BROKING

Notification
No new Notification messages
Dr Agarwal's Health Care IPO is Open!
Apply for the Dr Agarwal's Health Care IPO through UPI in just minutes.
Q3 FY'25 Results of Top Companies!
From Reliance Industries to TCS to HDFC Bank, check out the latest quarterly results with financial highlights, key performance metrics, and more!
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Dr Agarwal's IPO: Things Smart Investors Need to Know

Dr Agarwal's Health Care Limited, established in 2010, is a leading provider of eye care services in India. The company offers an extensive range of treatments, including cataract and refractive surgeries, consultations, diagnostics, non-surgical procedures, and the sale of optical products, contact lenses, and pharmaceutical items. As of September 30, 2024, its expansive network spans 14 states and 4 union territories, with 209 facilities, including 28 hubs and 165 spokes, catering to patients across metro and non-metro cities.

During the six months leading up to September 30, 2024, the company served 1.15 million patients and performed 140,787 surgeries. Known for advanced procedures like robotic cataract surgery, LASIK, SMILE, and corneal transplants, Dr Agarwal's Health Care is well-positioned to capitalise on the growing demand for eye care services in India. With 737 skilled doctors, the IPO presents an opportunity for investors eyeing this thriving healthcare segment.

For more details, visit the Dr. Agarwal’s IPO page.

Dr Agarwal's IPO Details and Objectives

Details

Information

IPO Date

January 29, 2025 to January 31, 2025

Issue Size

7,53,04,970 shares

(aggregating up to ₹3,027.26 Cr)

Price Band

₹382 to ₹402 per share

Lot Size

35 shares

Listing At

BSE, NSE

Purpose of the IPO

  • Repayment or prepayment of specific borrowings, either partially or fully.

  • General corporate purposes.

  • Potential unidentified inorganic acquisitions.

Timeline of Dr Agarwal's Health Care IPO

Event

Date

IPO Open Date

Wednesday, January 29, 2025

IPO Close Date

Friday, January 31, 2025

Basis of Allotment

Monday, February 3, 2025

Initiation of Refunds

Tuesday, February 4, 2025

Credit of Shares to Demat

Tuesday, February 4, 2025

Listing Date

Wednesday, February 5, 2025

Cut-off time for UPI mandate confirmation

5 PM on January 31, 2025

Pricing & Lot Size of Dr Agarwal's IPO

Price Band for the IPO

  • ₹382 to ₹402 per share.

Minimum Lot Size and Application Details

Application

Lots

Shares

Amount

Retail (Min)

1

35

₹14,070

Retail (Max)

14

490

₹1,96,980

S-HNI (Min)

15

525

₹2,11,050

S-HNI (Max)

71

2,485

₹9,98,970

B-HNI (Min)

72

2,520

₹10,13,040

How to Apply for the Dr Agarwal's IPO?

Online Application Process

  • Log in to Your Trading Account

    Access your trading account through your broker’s platform.

  • Navigate to the IPO Section

    Go to the IPO section to view active IPO listings.

  • Select Dr. Agarwal’s IPO

    Find "Dr. Agarwal’s IPO" and click on the ‘Apply’ button.

  • Enter Application Details

    Specify the number of lots (minimum lot size: 35 shares) and the bid price within the range of ₹382 to ₹402 per share.

  • Provide Your UPI ID
    Enter your UPI ID for payment authorization. Ensure that sufficient funds are available in your linked account.

  • Review and Submit

    Verify all the details entered before submitting the application. Approve the UPI mandate before 5 PM on January 31, 2025, to complete your application process.

Financial Health and Performance

Key Financial Metrics

  • Total Assets: Grew from ₹1,026.13 crore in FY22 to ₹3,393.41 crore as of September 2024.

  • Revenue: Reached ₹837.94 crore in FY24.

  • Profit After Tax (PAT): Stood at ₹39.56 crore for September 2024.

  • Net Worth: Increased from ₹212.34 crore in FY22 to ₹1,502.67 crore as of September 2024.

  • Reserves and Surplus: Recorded at ₹1,509.11 crore (Sept 2024), growing steadily over the years.

  • Total Borrowings: Increased to ₹373.68 crore (Sept 2024) from ₹290.18 crore in FY22.

Recent Performance and Growth Prospects

  • The company has experienced significant growth in its total assets, reflecting its expanding scale of operations.

  • Revenue generation has consistently increased, showcasing robust business performance.

  • The company has maintained profitability, underlining its ability to generate sustainable earnings.

  • Strengthened net worth and reserves highlight financial stability and long-term growth potential.

  • The steady rise in reserves and surplus indicates strong financial management and reinvestment strategies.

  • An increase in borrowings suggests strategic investments to support future growth initiatives.

Investment Risks and Opportunities

Potential Risks of Investing in the IPO

  • The company’s increasing borrowings may indicate higher financial obligations, which could impact profitability in the long run.

  • Reliance on advanced technologies and procedures could pose a challenge if competitors adopt similar innovations, intensifying market competition.

Opportunities and Growth Potential

  • An expansive and well-established network across metro and non-metro cities positions the company to cater to a growing demand for eye care services in India.

  • The company’s expertise in advanced surgical procedures, such as robotic cataract surgery and LASIK, presents a competitive edge in the healthcare sector.

Key Performance Indicator (KPI)

KPI

Values

ROE

9.33%

ROCE

14.61%

RoNW

6.21

PAT Margin

6.90

Price to Book Value

7.96

Dr Agarwal's IPO Registrar & Lead Managers

Registrar

Lead Manager(s)

Kfin Technologies Limited

Kotak Mahindra Capital Company Limited, Morgan Stanley India Company Pvt Ltd, Jefferies India Private Limited, Motilal Oswal Investment Advisors Limited

Company Address of Dr Agarwal's Healthcare Limited

Dr. Agarwal's Health Care Limited

1 st Floor, Buhari Towers

No.4, Moores Road, Off Greams Road,

Near Asan Memorial School, Chennai 600 006

Phone: +91 44 4378 7777

Email: secretarial@dragarwal.com

Website: https://dragarwals.co.in/

Conclusion

Dr Agarwal's Health Care Limited's IPO highlights its strategic expansion and commitment to advanced eye care services. With a strong network of 209 facilities across 14 states and 4 union territories, the company has demonstrated steady growth in revenue, profitability, and financial stability. Its focus on cutting-edge procedures and increasing patient reach underscores its role in addressing India's growing eye care demand.

The IPO offers investors a glimpse into a thriving healthcare segment, backed by experienced leadership and robust operational metrics. Potential risks include increasing borrowings and competitive challenges. Nonetheless, the company's extensive presence, specialised expertise, and financial growth position it as a noteworthy player in India’s healthcare landscape.

Interested in more opportunities? Check out our Upcoming IPO section for new listings and don’t forget to check your IPO allotment status for Dr. Agarwal’s IPO. 

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

For All Disclaimers Click Here: https://bit.ly/3Tcsfuc

Share this article: 

Frequently Asked Questions

Who is the CEO of Dr Agarwals Health Care Limited?

Answer Field

The CEO of Dr Agarwal's Health Care Limited is Dr Adil Agarwal.

When will Dr Agarwals Health Care IPO open for subscription?

Answer Field
The IPO will open for subscription on Wednesday, January 29, 2025, and close on Friday, January 31, 2025.

What is the company’s core business, and how sustainable is its business model in the long term?

Answer Field

Dr Agarwal's Health Care Limited primarily operates in the eye care sector, offering services such as cataract and refractive surgeries, diagnostics, consultations, and the sale of optical products and pharmaceutical items. Its business model is sustainable in the long term due to its wide service network, advanced surgical procedures, and increasing demand for quality eye care in both metro and non-metro cities.

What is the issue size of Dr Agarwals Health Care IPO?

Answer Field

The issue size of the IPO is 7,53,04,970 shares, aggregating up to ₹3,027.26 crore.

What is pre-apply for Dr Agarwals IPO?

Answer Field

‘Pre-apply’ allows investors to place their IPO applications in advance through their trading platforms, ensuring readiness before the IPO officially opens. The application will be processed when the IPO subscription period begins.

When will I know if Dr Agarwals IPO order is placed?

Answer Field
You will receive confirmation once the UPI mandate for payment is approved, provided it is authorised before 5 PM on January 31, 2025.

What is the lot size and minimum order quantity of Dr Agarwals IPO?

Answer Field

The lot size is 35 shares, and the minimum order quantity for retail investors is 1 lot (35 shares).

What is the allotment date for Dr Agarwals Health Care IPO?

Answer Field

The basis of allotment will be finalised on Monday, February 3, 2025.

Who is the registrar of Dr Agarwals Health Care IPO?

Answer Field

The registrar for the IPO is Kfin Technologies Limited.

Are there any governance issues or red flags in the company’s leadership or board structure?

Answer Field

As of now, no governance issues or red flags have been publicly reported in the company’s leadership or board structure.

No Result Found

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5300+ Cr MTF Book

icon-with-text